Ribonuclease attenuates acute intestinal injury induced by intestinal ischemia reperfusion in mice

Xi-Yang Zhang1, Hai-Su Liang2, Jing-Juan Hu1

  • 1Department of Anesthesiology, Nan Fang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Insights

Ribonuclease (RNase) treatment protects against intestinal ischemia reperfusion (I/R) injury by reducing inflammation and apoptosis. This study shows RNase is a potential therapeutic for I/R injury.

Area of Science:

  • Gastroenterology
  • Immunology
  • Molecular Biology

Background:

  • Ribonuclease (RNase) has demonstrated organ-protective properties in various conditions.
  • The role of RNase in mitigating intestinal ischemia reperfusion (I/R) injury and its underlying mechanisms are not well understood.

Purpose of the Study:

  • To investigate the protective effects of RNase on intestinal I/R injury in a mouse model.
  • To explore the potential mechanisms by which RNase exerts its protective effects.

Main Methods:

  • A mouse model of intestinal I/R was established by clamping the superior mesenteric artery.
  • Mice were divided into sham, sham + RNase, I/R, and I/R + RNase groups.
  • RNase or saline was administered at specific time points during the experiment.

Main Results:

  • Intestinal I/R induced significant injury and increased extracellular RNA (exRNA) levels.
  • RNase treatment markedly reduced inflammatory cytokine production.
  • RNase administration inhibited intestinal apoptosis and downregulated toll-like receptor 3 expression.

Conclusions:

  • Elevated exRNAs appear to contribute to intestinal I/R injury.
  • Perioperative RNase treatment effectively attenuates intestinal I/R injury in mice.
  • RNase represents a promising therapeutic strategy for intestinal I/R injury.

Related Concept Videos